1
Radaelli Guido, Fleischer Daniel, Vick Bertrand, Caspari Matthew, Weissman Joseph, Rice David: Methods for concentrating microalgae. Aurora Biofuels, Radaelli Guido, Fleischer Daniel, Vick Bertrand, Caspari Matthew, Weissman Joseph, Rice David, WAHLSTEN Jennifer L, July 2, 2009: WO/2009/082696 (54 worldwide citation)

The present invention provides commercially viable, large-scale methods for concentrating microalgae with an average diameter of about 20 μm or less. The methods find use in concentrating microalgae with an average diameter of about 5 μm or less, for example, Nannochloropsis.


2
Chen Irvin Sy, Morizono Kouki: Targeting pseudotyped retroviral vectors. The Regents Of The University Of California, Chen Irvin Sy, Morizono Kouki, WAHLSTEN Jennifer L, December 15, 2005: WO/2005/118802 (10 worldwide citation)

The present invention relates to retroviral vectors, particularly lentiviral vectors, pseudotyped with Sindbis envelope and targeted to specific cell types via a targeting moiety linked to the envelope.


3
Felber Barbara K, Pavlakis George N: Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells. The Government Of The United States Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health, Felber Barbara K, Pavlakis George N, WAHLSTEN Jennifer L, July 26, 2007: WO/2007/084342 (10 worldwide citation)

The present invention provides for nucleic acids improved for the expression of interleukin-15 (IL-15) in mammalian cells. The invention further provides for methods of expressing IL-15 in mammalian cells by transfecting the cell with a nucleic acid sequence comprising a codon optimized IL-15 sequen ...


4
Amaral David G, Corbett Blythe A: Diagnostic biomarkers for neurodevelopmental disorders. The Regents Of The University Of California, Amaral David G, Corbett Blythe A, WAHLSTEN Jennifer L, November 16, 2006: WO/2006/121952 (5 worldwide citation)

The present invention provides methods of identifying biomarkers indicative of the presence of a neurodevelopmental disorder, including an autism spectrum disorder, in an individual, using cytometry and mass spectrometry. The invention further provides methods of using the identified biomarkers to d ...


5
HO MITCHELL: Anti-mesothelin antibodies. THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, Wahlsten Jennifer L, September 30, 2010: WO/2010/111282 (5 worldwide citation)

The present invention provides monoclonal anti-mesothelin antibodies and antibody fragments and methods for their use. The antibodies can be completely human.


6

7
Waibel Brian J, Krukonis Val J: Energy efficient separation of ethanol from aqueous solution. Dynasep, Waibel Brian J, Krukonis Val J, WAHLSTEN Jennifer L, December 4, 2008: WO/2008/147705 (3 worldwide citation)

The present invention provides methods and systems for extracting ethanol from an ethanol-water solution comprising (1) extracting ethanol from an ethanol-water solution with a first solvent comprising an esterified fatty acid, wherein the esterified fatty acid comprises a hydroxylated fatty acid co ...


8
Zhang James, Armstrong Joshua, Gutterson Neal: Increasing plant drought and cold resistance: aba + triazole. Mendel Biotechnology, Zhang James, Armstrong Joshua, Gutterson Neal, WAHLSTEN Jennifer L, January 18, 2007: WO/2007/008580 (3 worldwide citation)

The present application provides methods of imparting increased stress resistance on a plant by application of exogenous ABA and one or more triazole compounds, diniconazole, uniconazole and uniconazole-P.


9
Medrano Juan F, Rincon Gonzalo: Snps associated with fatty acid composition of bovine meat and milk. The Regents Of The University Of California, Medrano Juan F, Rincon Gonzalo, WAHLSTEN Jennifer L, January 15, 2009: WO/2009/009439 (2 worldwide citation)

The present invention provides compositions and methods for genotyping bovines including dairy cows and beef cattle More particularly, the invention is directed to single nucleotide polymorphisms in Stearoyl-CoA-Desaturase 5 (SCD5) Sterol regulatory element-binding protein-1 (SREBP1). SREBP cleavage ...


10
Garren Hideki, Leviten Michael, Solvason Nanette: Polynucleotide therapy. Bayhill Therapeutics, Garren Hideki, Leviten Michael, Solvason Nanette, WAHLSTEN Jennifer L, December 21, 2007: WO/2007/147011 (2 worldwide citation)

This invention provides methods of treating an autoimmune disease in a subject associated with one or more self-protein(s), polypeptide(s), or peptide(s) present in the subject non-physiologically comprising administering to the subject: a self-vector comprising an immunosuppressive vector backbone ...



Click the thumbnails below to visualize the patent trend.